NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · IEX Real-Time Price · USD
22.86
+0.16 (0.70%)
Mar 28, 2024, 1:56 PM EDT - Market open

NAMS Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Year 2023202220212020
Net Income
-176.94-22.63-41.79-5.75
Depreciation & Amortization
0.050.010.010
Share-Based Compensation
24.574.121.240
Other Operating Activities
11.129.1711.02-0.22
Operating Cash Flow
-141.2210.67-29.51-5.97
Capital Expenditures
-0.02-0.22-0.02-0.01
Investing Cash Flow
-0.02-0.22-0.02-0.01
Share Issuance / Repurchase
8.91396.9584.70
Debt Issued / Paid
00.75011.32
Other Financing Activities
--5.79--
Financing Cash Flow
8.91391.9184.711.32
Net Cash Flow
-132.33402.3555.175.34
Free Cash Flow
-141.2410.44-29.54-5.98
Free Cash Flow Margin
-1002.43%10.17%--
Free Cash Flow Per Share
-1.450.13-1.66-0.91
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).